<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">patmedfar</journal-id><journal-title-group><journal-title xml:lang="en">Patient-Oriented Medicine and Pharmacy</journal-title><trans-title-group xml:lang="ru"><trans-title>Пациентоориентированная медицина и фармация</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-1924</issn><publisher><publisher-name>LLC Izdatelstvo OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2949-1924-0137</article-id><article-id custom-type="elpub" pub-id-type="custom">patmedfar-232</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL CHEMISTRY, PHARMACOGNOSY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ХИМИЯ, ФАРМАКОГНОЗИЯ</subject></subj-group></article-categories><title-group><article-title>Development of a wound dressing based on modified polyurethane foam to localize bacteriophage action in the wound</article-title><trans-title-group xml:lang="ru"><trans-title>Разработка раневого покрытия на основе модифицированного пенополиуретана для локализации действия бактериофага в ране</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6454-1346</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жукова Ольга Вячеславовна - д. фарм. н., доцент, зав. кафедрой фармацевтической химии и фармакогнозии</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Olga V. Zhukova - Dr. Sci. (Pharm.), Associate Professor, Head of the Department of Pharmaceutical Chemistry and Pharmacognosy</p><p>Nizhny Novgorod</p></bio><email xlink:type="simple">ov-zhukova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8387-6344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Широкова</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shirokova</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Широкова Ирина Юрьевна - к. м. н., врач-медицинский микробиолог, зав. бактериологической лабораторией Университетской клиники</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Irina Yu. Shirokova - Cand. Sci. (Med.), medical microbiologist . , head of the bacteriological laboratory of the University Clinic</p><p>Nizhny Novgorod</p></bio><email xlink:type="simple">shirokova_i@pimunn.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8578-3600</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белянина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyanina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белянина Наталья Александровна - биолог бактериологической лаборатории Университетской клиники</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Natalia A. Belyanina - biologist of the bacteriological laboratory of the University Clinic</p><p>Nizhny Novgorod</p></bio><email xlink:type="simple">belyanina_n@pimunn.net</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2026</year></pub-date><volume>4</volume><issue>2</issue><fpage>16</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Zhukova O.V., Shirokova I.Y., Belyanina N.A., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Жукова О.В., Широкова И.Ю., Белянина Н.А.</copyright-holder><copyright-holder xml:lang="en">Zhukova O.V., Shirokova I.Y., Belyanina N.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pomph.ru/jour/article/view/232">https://www.pomph.ru/jour/article/view/232</self-uri><abstract><sec><title>Background</title><p>Background. The problem of antimicrobial resistance is one of the main challenges of modern medicine. Bacteriophages represent a promising approach in the treatment of infectious diseases, particularly in the treatment of wound infections. However, the use of bacteriophages in clinical practice is associated with a number of technological problems, the key ones being the methods of their delivery to the site of infection and maintaining their therapeutic concentration in the area of clinical interest. To achieve this goal, the use of polymeric materials as bacteriophage carriers holds promise. Polyurethane foam is a potential material for the creation of wound dressings due to its porous structure, elasticity, and biocompatibility.</p></sec><sec><title>Objective</title><p>Objective. The aim of this study was to develop a prototype wound dressing based on modified polyurethane foam for the immobilization of bacteriophages and their controlled release in the wound.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Technical polyurethane foam (OOO Sintez OKA, Dzerzhinsk, Nizhny Novgorod Region) was used in the study. The modification of polyurethane foam plates was carried out by oxidative polymerization of catecholamine derivatives. Physicochemical properties were determined by comparing the absorption capacity by mass and volume, porosity, and droplet imbibition time. To assess the potential of the material as a platform for delivering bacteriophages to the clinical site of interest and ensuring uniform release, Kruvchinsky dialysis through a semipermeable membrane was used. Bacteriophage titer was determined using the Appelman method.</p></sec><sec><title>Results</title><p>Results. A comparative assessment of the physicochemical properties of standard and modified polyurethane foam, including porosity, absorption capacity, and hydrophilicity, was conducted. The viability of immobilized bacteriophages and their release kinetics were studied using Kruvchinsky dialysis. The results showed that the modification significantly improves the hydrophilic properties of the material (droplet imbibition time is reduced from 53 minutes to 4.3 seconds) and ensures the preservation of bacteriophage lytic activity for 8 hours. Appelman titration demonstrated that the modified polyurethane foam maintains the viability of bacteriophages at dilutions up to 10⁻⁵, compared to 10⁻³ for conventional polyurethane foam. The developed coating can be used to treat infected wounds, providing controlled release of bacteriophages and maintaining therapeutic concentrations in the area of clinical interest.</p></sec><sec><title>Conclusions</title><p>Conclusions. The modified polyurethane foam represents a promising platform for creating biomimetic wound dressings capable of effectively delivering bacteriophages to the site of infection and maintaining their therapeutic concentrations. The developed material may find application in the treatment of infected wounds, particularly those caused by antibiotic-resistant staphylococcal strains.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Актуальность</title><p>Актуальность. Проблема антимикробной резистентности является одним из главных вызовов современной медицины. Бактериофаги представляют собой перспективное направление в лечении инфекционных заболеваний, особенно при терапии раневых инфекций. Однако применение бактериофагов в клинической практике сопряжено с рядом технологических проблем, ключевыми из которых являются способы их доставки в очаг инфекции и поддержание их терапевтической концентрации в зоне клинического интереса. Для достижения этой цели перспективным является использование полимерных материалов в качестве носителей бактериофагов. Пенополиуретан является потенциальным материалом для создания раневых покрытий благодаря своей пористой структуре, эластичности и биосовместимости.</p></sec><sec><title>Цель</title><p>Цель. Разработка прототипа раневого покрытия на основе модифицированного пенополиуретана для иммобилизации бактериофагов и обеспечения их контролируемого высвобождения в ране.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В работе использовали технический пенополиуретан (ООО «Синтез ОКА», Дзержинск, Нижегородская обл.). Модификацию пластин пенополиуретана проводили методом окислительной полимеризации катехоламиновых производных. Определяли физико-химические свойства путём сравнения поглотительной способности по массе и объёму, пористости, времени поглощения (имбибиции) капли. Для оценки возможности использования материала в качестве платформы для доставки бактериофага в зону клинического интереса и обеспечения равномерности его высвобождения был использован метод диализа по Крувчинскому через полупроницаемую мембрану. Титр бактериофага определяли по методу Аппельмана.</p></sec><sec><title>Результаты</title><p>Результаты. Проведена сравнительная оценка физико-химических свойств обычного и модифицированного пенополиуретана, включая пористость, поглотительную способность и гидрофильность. Исследована жизнеспособность иммобилизованных бактериофагов и кинетика их высвобождения методом диализа по Крувчинскому. Результаты показали, что модификация значительно улучшает гидрофильные свойства материала (время впитывания капли снижается с 53 минут до 4,3 секунд) и обеспечивает сохранение литической активности бактериофагов в течение 8 часов. Титрование по методу Аппельмана продемонстрировало, что модифицированный пенополиуретан поддерживает жизнеспособность бактериофагов при разведении до 10⁻⁵, в то время как для обычного пенополиуретана этот показатель составил 10⁻³. Разработанное покрытие может применяться для лечения инфицированных ран, обеспечивая контролируемое высвобождение бактериофагов и поддержание терапевтической концентрации в зоне клинического интереса.</p></sec><sec><title>Выводы</title><p>Выводы. Модифицированный пенополиуретан представляет собой перспективную платформу для создания биомиметических раневых покрытий, способных обеспечивать эффективную доставку бактериофагов в очаг инфекции и поддержание их терапевтической концентрации. Разработанный материал может найти применение в лечении инфицированных ран, особенно при инфекциях, вызванных антибиотикорезистентными штаммами стафилококков.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>пенополиуретан</kwd><kwd>окислительная полимеризация производных катехоламинов</kwd><kwd>бактериофаги</kwd><kwd>раневое покрытие</kwd><kwd>фаготерапия</kwd><kwd>модификация полимеров</kwd></kwd-group><kwd-group xml:lang="en"><kwd>polyurethane foam</kwd><kwd>oxidative polymerization of catecholamine derivatives</kwd><kwd>bacteriophages</kwd><kwd>wound dressing</kwd><kwd>phage therapy</kwd><kwd>polymer modification</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках Государственного задания Минздрава России № 056-03-2026-123 «Разработка раневого покрытия на основе модифицированного пенополиуретана для самостоятельного применения и для доставки антимикробных средств с целью поддержания их необходимой концентрации в зоне клинического интереса».</funding-statement><funding-statement xml:lang="en">The work was carried out within the framework of the State Assignment of the Ministry of Health of the Russian Federation No. 056-03-2026-123 "Development of a wound dressing based on modified polyurethane foam for independent use and for the delivery of antimicrobial agents in order to maintain their required concentration in the area of clinical interest."</funding-statement></funding-group></article-meta></front><body><sec><title>Introduction</title><p>The problem of antimicrobial resistance is one of the main challenges of modern medicine, which necessitates the search for alternative methods of combating bacterial infections. Bacteriophages represent a promising approach in the treatment of infectious diseases, particularly in the therapy of wound infections [<xref ref-type="bibr" rid="cit1">1</xref>]. However, the use of bacteriophages in clinical practice is associated with a number of technological challenges, the key ones being the methods of their delivery to the site of infection and maintaining their therapeutic concentration in the area of clinical interest [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>The effectiveness of topical phage therapy is determined by adherence to principles developed on the basis of recent experimental and clinical studies. One of the main requirements is the creation of a phage concentration in the area of clinical interest exceeding the threshold value of C = 10⁸-10⁹ PFU/mL, which is 100 times higher than the concentration of target bacteria [<xref ref-type="bibr" rid="cit2">2</xref>]. To achieve this goal, the use of polymeric materials as bacteriophage carriers holds promise [<xref ref-type="bibr" rid="cit3">3</xref>].</p><p>Polyurethane foam is a potential material for the creation of wound dressings due to its porous structure, elasticity, and biocompatibility [<xref ref-type="bibr" rid="cit4">4</xref>]. However, native polyurethane foam possesses hydrophobic properties, which limits its application for wound dressings requiring active absorption of exudate. Surface modification of polyurethane foam is a promising approach for imparting hydrophilicity, adhesive, and antibacterial properties to the material [5, 6, 7].</p><p>Oxidative polymerization of catecholamine derivatives was used as the modification reaction, resulting in the formation of a biomimetic coating on the surface with unique properties [<xref ref-type="bibr" rid="cit7">7</xref>]. The presence of free hydroxyl and amino groups provides adhesive properties and the possibility of immobilizing biologically active agents, including antibiotics and bacteriophages [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>The objective of this study was to develop a prototype wound dressing based on modified polyurethane foam for the immobilization of bacteriophages and their controlled release in the wound.</p></sec><sec><title>Materials and Methods</title><p>The following materials were used in the study: technical polyurethane foam (Sintez OKA); staphylococcal bacteriophage "Staphylophage" manufactured by the branch of JSC NPO "Microgen" in Nizhny Novgorod "IMBIO," a sterile purified filtrate of phage lysates of bacteria of the genus Staphylococcus with an Appelman activity of not less than 10⁻⁵; tris-(hydroxymethyl)-aminomethane (Pharmpur® Ph Eur, BP, Scharlab, Spain); isotonic NaCl solution (OOO "Grotex," Russia); Staphylococcus aureus culture, clinical strain No. 229 from the working collection of the bacteriological laboratory of the University Clinic "PIMU," isolated from a patient with burn wounds; GRM agar.</p><p>Modification of polyurethane foam. Plates were cut from technical polyurethane foam measuring 2×2×0.5 cm. Modification of polyurethane foam plates was carried out by oxidative polymerization of catecholamine derivatives. A 0.01 M solution of tris-(hydroxymethyl)-aminomethane was prepared, to which dopamine hydrochloride was added at a concentration of 2 mg/mL. The pH of the solution was adjusted to 8.6 to initiate polymerization. Polyurethane foam samples were completely immersed in the resulting solution and kept at room temperature in air under natural lighting for 24 hours. After polymerization, the samples were washed with distilled water and then dried in a drying oven at 45°C for 4 hours. The success of modification was assessed visually by the characteristic color change of the material to dark brown and black-brown (according to the RAL classification), with possible uneven coloration ("marbling").</p><p>Determination of physicochemical properties</p><p>Determination of absorption capacity by mass. Polyurethane foam samples of standard shape (parallelepiped plates) were weighed on an analytical balance (m₀, g) and immersed in distilled water for 10 minutes. After removing excess water, the samples were reweighed (m₁, g). Absorption capacity was calculated using the following formula:</p><p>B = (m₁ - m₀) / m₀ × 100% (1), where</p><p>B — absorption capacity of the material by mass, %;</p><p>m₁ — mass of the material sample after water absorption, g;</p><p>m₀ — mass of the initial material, g.</p><p>All measurements were performed in six replicates.</p><p>Determination of absorption capacity by volume. The initial volume of the sample (V₀) was measured, after which the sample was completely saturated with distilled water. The amount of absorbed liquid (Vₐᵦₛ) was determined by the difference in volumes, and the absorption coefficient was calculated using the following formula:</p><p>K = (Vₐᵦₛ / V₀) × 100%, where</p><p>K — water absorption coefficient of the material, %;</p><p>Vₐᵦₛ — volume of liquid absorbed by the material sample, cm³/mL;</p><p>V₀ — initial volume of the sample, cm³/mL.</p><p>All measurements were performed in six replicates.</p><p>Determination of porosity. Samples were weighed (m₀, g), completely saturated with distilled water, and reweighed (m₁, g). Porosity was calculated using the following formula:</p><p>P = (m₁ - m₀) / V_H₂O × 100%, where</p><p>P — porosity of the material, %;</p><p>m₀ — mass of the initial material sample, g;</p><p>m₁ — mass of the material sample after complete saturation with liquid, g;</p><p>V_H₂O — volume of water required for complete saturation of the sample.</p><p>All measurements were performed in six replicates.</p><p>Determination of droplet imbibition time. A drop of distilled water with a volume of 10 µL was applied to the surface of the sample using a microdispenser. The time for complete absorption of the drop was recorded with a stopwatch. For all indicators, the result was the arithmetic mean of at least five measurements.</p><p>Dialysis of bacteriophages by the Kruvchinsky method. The kinetics of bacteriophage release were studied by the Kruvchinsky dialysis method through a semipermeable membrane. A polyurethane foam plate saturated with bacteriophage was placed in a dialysis tube closed at one end with a cellulose membrane. The tube was immersed in isotonic NaCl solution and incubated at 37°C. Samples were taken at 1, 3, 5, and 8 hours of dialysis, with the medium volume adjusted to the initial value after each sampling.</p><p>Assessment of bacteriophage viability on modified polyurethane foam substrate. Polyurethane foam samples were saturated with bacteriophage in an amount equal to ½ of the maximum absorption volume. The saturated samples were placed in Petri dishes with GRM agar, onto which a suspension of S. aureus microorganisms at a concentration of 1×10⁵ CFU/mL (corresponding to an optical density of 0.5-0.6 units on the McFarland scale) had been previously applied. The dishes were incubated at 37°C for 24 hours. The degree of lysis was assessed on a five-point scale:</p><p>The procedure was performed in three replicates to ensure the representativeness of the data obtained and to minimize random errors.</p><p>Analysis of bacteriophage lytic activity kinetics. A suspension of S. aureus at a concentration of 1×10⁵ CFU/mL (corresponding to an optical density of 0.5-0.6 units on the McFarland scale) was prepared and evenly applied to dried Petri dishes with GRM agar. From the samples obtained during dialysis (1, 3, 5, and 8 hours), 20 µL of dialysate was taken and applied to the dishes. Sampling was performed in triplicate for each experimental time point. The dishes were incubated at 37°C for 24 hours, after which the degree of lysis was assessed.</p><p>Determination of bacteriophage titer by the Appelman method. Twelve sterile bacteriological test tubes with 4.5 mL of sterile nutrient broth were prepared. Into the 1st test tube, 0.5 mL of the studied phage was introduced with a sterile pipette. The contents of the test tube were mixed, and 0.5 mL from the 1st test tube was transferred to the 2nd, mixed, and from the 2nd test tube transferred to the 3rd, and so on up to the 10th inclusive. From the 10th test tube, 0.5 mL was removed. The 11th and 12th test tubes served as controls (test tube 11 — microorganism growth control, containing 4.5 mL of broth and 0.2 mL of broth culture of S. aureus; test tube 12 — nutrient broth sterility control, containing 4.5 mL of broth without the addition of bacterial culture of S. aureus and bacteriophage). Bacteriophage dilutions from -10 to -10,000,000,000 (10⁻¹ — 10⁻¹⁰) were obtained. Next, 0.2 mL of 18-24-hour broth culture of S. aureus bacteria sensitive to the titrated bacteriophage was added to all 10 test tubes of the prepared dilution series. The rack with test tubes was incubated in a thermostat at 37°C. Results were recorded after 18-20 hours. The titer was considered to be the maximum dilution of bacteriophage at which complete lysis of the phage-sensitive S. aureus culture was observed.</p><p>Statistical analysis. Upon confirmation of normal distribution, parametric comparison of data (t-test for two independent samples) was used for analysis. If the data did not conform to normal distribution, the nonparametric method of sample comparison (Mann-Whitney test) was used. Significance of differences was determined at a significance level of p &lt; 0.05.</p></sec><sec><title>Results and Discussion</title><p>Effect of modification on the physicochemical properties of polyurethane foam. The results of absorption capacity assessment are presented in Table 1. By mass, the absorption capacity of polyurethane foam (PU) was 3459.6 ± 197.8%, while that of modified polyurethane foam (MPU) was 3395.7 ± 205.26%. By volume, the value for PU was 217 ± 22.72%, and for MPU — 213.42 ± 23.3%. The tendency for a slight decrease in moisture capacity of MPU is associated with a reduction in pore size due to adsorption of polymerization products of catecholamine derivatives, which is consistent with porosity data (Table 1).</p><p>Table 1. Comparison of the absorption capacity of the original and modified polyurethane foam</p><p>IndicatorPU (M ± SD)MPU (M ± SD)p-valueBy mass, %3459.60 ± 197.803395.70 ± 205.26p &gt; 0.05By volume, %217.00 ± 22.72213.42 ± 23.30p &gt; 0.05</p><p>Notes: PU — polyurethane foam; MPU — modified polyurethane foam.</p><p>The results of porosity determination are presented in Table 2. For PU, the average porosity was 97.04 ± 0.86%, while for MPU it was 95.36 ± 4.29%. The decrease in porosity of MPU can be explained by the adsorption of oxidative polymerization products of catecholamine derivatives on the pore surface, which leads to a reduction in their effective diameter.</p><p>Table 2. Porosity of the original and modified polyurethane foam</p><p>SamplePorosity, % (M ± SD)p-valuePolyurethane foam97.04 ± 0.86p &gt; 0.05Modified polyurethane foam95.36 ± 4.29 </p><p>The imbibition time of one drop of distilled water with a volume of 10 µL is an indicator of material hydrophilicity. For PU, the average absorption time was 53 min 48 s ± 14 min 6 s, which indicates pronounced hydrophobic properties of the material. After modification of PU, the absorption time was statistically significantly reduced to 4.3 ± 2.44 seconds (p &lt; 0.05), indicating that the material acquired pronounced hydrophilic properties.</p><p>The obtained results of physicochemical property assessment demonstrate that modification radically changes the surface properties of PU, transforming the hydrophobic material into a modified one with hydrophilic properties (MPU). This is of great importance for application as a wound dressing, as it ensures effective absorption of wound exudate.</p><p>Assessment of bacteriophage viability and lytic activity on polyurethane foam plates. MPU demonstrated maximum lytic activity ("++++") at all dialysis time points (1, 3, 5, and 8 hours), indicating complete preservation of bacteriophage viability. For PU, maximum activity was observed only in the first 3 hours, while at 5 and 8 hours of dialysis a decrease in activity was noted ("++" and "++", respectively) with the formation of a lysis zone with a large number of secondary growth colonies (Table 3).</p><p>Table 3. Comparison of the degree of bacterial lysis by dialysate of polyurethane foam and modified polyurethane foam</p><p>Sample1 hour3 hours5 hours8 hoursMPU++++++++++++++++PU++++++++++++</p><p>The obtained results indicate that modification not only does not reduce but actually promotes the preservation of bacteriophage viability during their immobilization and subsequent release.</p><p>Bacteriophage titration. The results of bacteriophage titer determination by the Appelman method for PU and MPU are presented in Tables 4 and 5.</p><p>Table 4. Titration of bacteriophage in polyurethane foam dialysate</p><p>Table 5. Titration of bacteriophage in dialysate of modified polyurethane foam</p><p>The titration data show that in bacteriophage samples released from MPU, complete lysis of the bacterial culture was observed at all studied dilutions (up to 10⁻⁵) at all time points. This indicates the preservation of high bacteriophage lytic activity at a level of not less than 10⁵ PFU/mL.</p><p>In the case of PU, after only 3 hours of dialysis the bacteriophage titer decreased to 10³, after 5 hours — to 10², and by 8 hours growth of S. aureus was observed at all dilutions, indicating almost complete loss of lytic activity.</p><p>The obtained results demonstrate that MPU ensures long-term preservation of viability and lytic activity of immobilized bacteriophages, which is critically important for application as a wound dressing. The modifying coating on PU likely creates a protective microenvironment for bacteriophages, protecting them from denaturation and loss of activity.</p></sec><sec><title>Study Limitations</title><p>A limitation of this study was its in vitro nature. Static, as well as simple dynamic in vitro models, do not account for active transport of substances, metabolic activity of tissues, or the influence of enzyme systems. Unlike a living organism, there is no blood flow or lymphatic drainage here, which constantly maintain a concentration gradient. The model is also limited by the use of standardized buffer solutions. In real conditions, diffusion is affected, in addition to pH, by the viscosity of biological media and the presence of specific proteins that bind active substances and alter their transport properties. The semipermeable membranes used have a fixed pore size and a specific chemical composition. They cannot mimic the complex structure of biological barriers, their selective permeability, the presence of ion channels, receptors, and transport systems. This leads to the fact that the rate of substance release in vitro may differ significantly from actual bioavailability.</p></sec><sec><title>Conclusion</title><p>The conducted study demonstrated the effectiveness of polyurethane foam modification for creating wound dressings with immobilized bacteriophages. Modification leads to a radical change in the surface properties of the material, transforming hydrophobic polyurethane foam into a hydrophilic one: the imbibition time of a water drop is reduced from 53 min to 4.3 s, which ensures effective absorption of wound exudate.</p><p>The key result of the work is the establishment of MPU's ability to maintain the viability and lytic activity of immobilized bacteriophages. Appelman titration showed that the modified material ensures the preservation of bacteriophage activity at a level of not less than 10⁵ PFU/mL for 8 hours of dialysis, whereas for PU almost complete loss of activity was observed by this time.</p><p>PU modification not only improves the hydrophilicity of the material but also imparts adhesive, antibacterial, antioxidant, and other properties, which further enhances the therapeutic potential of the developed dressing through effective immobilization of bacteriophages and their controlled release into the wound environment.</p><p>Thus, MPU represents a promising platform for creating biomimetic wound dressings capable of ensuring effective delivery of bacteriophages to the site of infection and maintaining their therapeutic concentration. The developed material may find application in the treatment of infected wounds, particularly those caused by antibiotic-resistant staphylococcal strains.</p><p>Promising directions for further research include studying the kinetics of phage release under conditions simulating the wound environment, as well as conducting preclinical trials of the effectiveness of the developed dressing on experimental models of infected wounds.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ibrahim R, Aranjani JM, Kalikot Valappil V, Nair G. Unveiling the potential bacteriophage therapy: a systematic review. Future Sci OA. 2025 Dec;11(1): 2468114. doi: 10.1080/20565623.2025.2468114.</mixed-citation><mixed-citation xml:lang="en">Ibrahim R, Aranjani JM, Kalikot Valappil V, Nair G. Unveiling the potential bacteriophage therapy: a systematic review. Future Sci OA. 2025 Dec;11(1): 2468114. doi: 10.1080/20565623.2025.2468114.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Погодин ИЕ, Самойленко ВМ, Киргинцев АГ, Лузан АС. Возможности и перспективы использования бактериофагов в лечении хронических ран мягких тканей. Вестник экспериментальной и клинической хирургии. 2021;14(2):168-174. doi: 10.18499/2070-478X-2021-14-2-168-174</mixed-citation><mixed-citation xml:lang="en">Pogodin IE, Samoylenko VM, Kirgintsev AG, Luzan AS. Possibilities and Prospects of Application of Bacteriophages in the Treatment of Chronic Soft Tissue Wounds. Journal of Experimental and Clinical Surgery. 2021;14(2):168-174. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ковязина Н.А., Лукин П.С., Функнер Е.В., и др. Подходы к конструированию полимерных раневых покрытий с бактериофагами. Медицинский альманах. 2013;2(26):72-74.</mixed-citation><mixed-citation xml:lang="en">Kovyazina N.A., Lukin P.S., Funkner E.V., et al. Approaches to the design of polymer wound dressings with bacteriophages. Medical Almanac. 2013;2(26):72-74.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dhyani A, Repetto T, VanAken S, et al. Antimicrobial wound dressings for full-thickness infected burn wounds. Shock. 2024 Oct 1;62(4):588-595. doi: 10.1097/SHK.0000000000002426.</mixed-citation><mixed-citation xml:lang="en">Dhyani A, Repetto T, VanAken S, et al. Antimicrobial wound dressings for full-thickness infected burn wounds. Shock. 2024 Oct 1;62(4):588-595. doi: 10.1097/SHK.0000000000002426.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M, Liu T, Chen X, et al. Nano-silver-incorporated biomimetic polydopamine coating on a thermoplastic polyurethane porous nanocomposite as an efficient antibacterial wound dressing. J Nanobiotechnology. 2018 Nov 12;16(1):89. doi: 10.1186/s12951-018-0416-4.</mixed-citation><mixed-citation xml:lang="en">Liu M, Liu T, Chen X, et al. Nano-silver-incorporated biomimetic polydopamine coating on a thermoplastic polyurethane porous nanocomposite as an efficient antibacterial wound dressing. J Nanobiotechnology. 2018 Nov 12;16(1):89. doi: 10.1186/s12951-018-0416-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dai S, Zang X, Zhang X, et al. Highly elastic lig-nin-based waterborne polyurethane with light color and its application in functional fabric coatings. Int J Biol Macromol. 2025 Apr;302:140521. doi: 10.1016/j.ijbiomac.2025.140521.</mixed-citation><mixed-citation xml:lang="en">Dai S, Zang X, Zhang X, et al. Highly elastic lig-nin-based waterborne polyurethane with light color and its application in functional fabric coatings. Int J Biol Macromol. 2025 Apr;302:140521. doi: 10.1016/j.ijbiomac.2025.140521.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng D, Huang C, Zhu X, et al. Performance of Polydopamine Complex and Mechanisms in Wound Healing. Int J Mol Sci. 2021 Sep 29;22(19): 10563. doi: 10.3390/ijms221910563.</mixed-citation><mixed-citation xml:lang="en">Zheng D, Huang C, Zhu X, et al. Performance of Polydopamine Complex and Mechanisms in Wound Healing. Int J Mol Sci. 2021 Sep 29;22(19): 10563. doi: 10.3390/ijms221910563.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Y, Yang L, Zhang J, et al. Polydopamine antibacterial materials. Mater Horiz. 2021 Jun 1;8(6): 1618-1633. doi: 10.1039/d0mh01985b.</mixed-citation><mixed-citation xml:lang="en">Fu Y, Yang L, Zhang J, et al. Polydopamine antibacterial materials. Mater Horiz. 2021 Jun 1;8(6): 1618-1633. doi: 10.1039/d0mh01985b.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Белозерская Г.Г., Бычичко Д.Ю., Кабак В.А. и др. Создание новых гемостатических покрытий локального действия на основе альгината натрия. Клиническая физиология кровообращения. 2018;15(3):222-229. doi: 10.24022/1814-6910-2018-15-3-222-229</mixed-citation><mixed-citation xml:lang="en">Belozerskaya G.G., Bychichko D.Yu., Kabak V.A. et al. Creation of new local hemostatic coatings based on sodium alginate. Clinical physiology of blood circulation. 2018; 15(3):222-229.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Истранов Л.П., Абоянц Р.К., Белозерская Г.Г. и др. Местные гемостатические средства на основе коллагена. Фармация. 2007;7:29-32.</mixed-citation><mixed-citation xml:lang="en">Istra-nov L.P., Aboyants R.K., Belozerskaya G.G. et al. Local hemostatic agents based on collagen. Pharmacy. 2007;7:29-32.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
